A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Trials
; 21(1): 1005, 2020 Dec 09.
Article
in En
| MEDLINE
| ID: mdl-33298149
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Venous Thromboembolism
/
SARS-CoV-2
/
COVID-19
/
Inflammation
Type of study:
Clinical_trials
/
Incidence_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Trials
Year:
2020
Document type:
Article